Rajinder Suri

Rajinder as CEO-DCVMN International is responsible for providing leadership, shaping strategic vision, governance and overall operational excellence of DCVMN. Rajinder has been appointed as committee delegate on GAVI-PPC effective 1st January 2024, is a member of GAVI’s Vaccine Investment Strategy (VIS) Steering Committee 2024, a permanent member of CEPI’s Joint Coordination Group (JCG), 2023-24 and a member of PAVMs Talent Development WS as well as Steering Committee member of the Regional Vaccine Manufacturing Collaborative (RVMC). In response to un-precedented challenge posed by COVID-19, Rajinder has actively participated in global strategic initiatives alongside COVAX partners-WHO, GAVI, CEPI, UNICEF and various other international organizations and industry associations. Rajinder has contributed as a member of several advisory expert groups including COVAX Manufacturing & Supply Chain Task Force Leadership Team, G-20 Health Working Group and Market Design and Demand Intelligence pillar of PAVM. He is on the Governing Board of Life Sciences Skill Development Council (LSSSDC). With over 25 years of top management experience in the industry, Rajinder has served on the Board of Directors of the Indian subsidiary of Sanofi Pasteur and held the position of CEO-Panacea Biotec. Rajinder has served earlier as Member-GAVI-PPC as well as Vice-President, DCVMN Executive Committee from 2014-16 He has played a lead role in negotiations & interactions with Ministry of Health, Government of India, UN agencies and other Global organizations. Rajinder carries strong value-based leadership qualities & multicultural flexibility. A good communicator with consultative management style, strong negotiation skills and exceptional problem solving & conflict resolution abilities.